These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37676606)

  • 21. Artificial intelligence: Machine learning approach for screening large database and drug discovery.
    Parvatikar PP; Patil S; Khaparkhuntikar K; Patil S; Singh PK; Sahana R; Kulkarni RV; Raghu AV
    Antiviral Res; 2023 Dec; 220():105740. PubMed ID: 37935248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-MGCL: Molecule Graph Contrastive Learning Based on Transformer for Molecular Property Prediction.
    Guan X; Zhang D
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(6):3851-3862. PubMed ID: 37856269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep Learning in Drug Discovery.
    Gawehn E; Hiss JA; Schneider G
    Mol Inform; 2016 Jan; 35(1):3-14. PubMed ID: 27491648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of artificial intelligence in drug design: A review.
    Singh S; Kaur N; Gehlot A
    Comput Biol Med; 2024 Sep; 179():108810. PubMed ID: 38991316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance and robustness of small molecule retention time prediction with molecular graph neural networks in industrial drug discovery campaigns.
    Vik D; Pii D; Mudaliar C; Nørregaard-Madsen M; Kontijevskis A
    Sci Rep; 2024 Apr; 14(1):8733. PubMed ID: 38627535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graph neural networks for automated de novo drug design.
    Xiong J; Xiong Z; Chen K; Jiang H; Zheng M
    Drug Discov Today; 2021 Jun; 26(6):1382-1393. PubMed ID: 33609779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial intelligence for skin permeability prediction: deep learning.
    Ita K; Roshanaei S
    J Drug Target; 2024 Dec; 32(3):334-346. PubMed ID: 38258521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep learning tools to accelerate antibiotic discovery.
    Cesaro A; Bagheri M; Torres M; Wan F; de la Fuente-Nunez C
    Expert Opin Drug Discov; 2023; 18(11):1245-1257. PubMed ID: 37794737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives on the use of machine learning for ADME prediction at AstraZeneca.
    Gawehn E; Greene N; Miljković F; Obrezanova O; Subramanian V; Trapotsi MA; Winiwarter S
    Xenobiotica; 2024 Jul; 54(7):368-378. PubMed ID: 39166404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery.
    Bhatia AS; Saggi MK; Kais S
    J Chem Inf Model; 2023 Nov; 63(21):6476-6486. PubMed ID: 37603536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A renaissance of neural networks in drug discovery.
    Baskin II; Winkler D; Tetko IV
    Expert Opin Drug Discov; 2016 Aug; 11(8):785-95. PubMed ID: 27295548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the effect of chemicals on fruit using graph neural networks.
    Han J; Li T; He Y; Yang Z
    Sci Rep; 2024 Apr; 14(1):8203. PubMed ID: 38589529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial intelligence: Its role in dermatopathology.
    Jartarkar SR
    Indian J Dermatol Venereol Leprol; 2023; 89(4):549-552. PubMed ID: 36688886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep Learning in Structure-Based Drug Design.
    Anighoro A
    Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries.
    Bian Y; Xie XQ
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could advances in representation learning in Artificial Intelligence provide the new paradigm for data integration in drug discovery?
    Vijayan V; Rouillard AD; Rajpal DK; Agarwal P
    Expert Opin Drug Discov; 2019 Mar; 14(3):191-194. PubMed ID: 30696299
    [No Abstract]   [Full Text] [Related]  

  • 40. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.